Belite Bio, Inc (ADR)
General ticker "BLTE" information:
- Sector: Health Care
- Industry: Pharmaceuticals
- Capitalization: $2.1B (TTM average)
Belite Bio, Inc (ADR) follows the US Stock Market performance with the rate: 38.9%.
Estimated limits based on current volatility of 5.0%: low 143.82$, high 158.99$
Factors to consider:
- Total employees count: 16 as of 2022
- Current price 85.3% above estimated high
- Earnings for 9 months up through Q3 are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2024-12-31 to 2026-12-31
- 2024-12-31 to 2025-12-31 estimated range: [34.85$, 81.63$]
- 2025-12-31 to 2026-12-31 estimated range: [24.04$, 59.33$]
Financial Metrics affecting the BLTE estimates:
- Negative: with PPE of -53.2 at the end of fiscal year the price was very high
- Negative: negative Operating income
- Negative: Operating cash flow per share per price, % of -1.52 <= 0.33
- Positive: Shareholder equity ratio, % of 95.85 > 63.39
- Positive: Interest expense per share per price, % of 0 <= 0.01
- Positive: -14.38 < Investing cash flow per share per price, % of -5.76
- Negative: negative Industry operating cash flow (median)
- Positive: Industry inventory ratio change (median), % of 0 <= 0
- Negative: negative Net income
Short-term BLTE quotes
Long-term BLTE plot with estimates
Financial data
| YTD | 2022-12-31 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Operating Revenue | $0.00MM | $0.00MM | $0.00MM |
| Operating Expenses | $12.82MM | $31.67MM | $40.00MM |
| Operating Income | $-12.82MM | $-31.67MM | $-40.00MM |
| Non-Operating Income | $0.17MM | $0.04MM | $3.86MM |
| Interest Expense | $0.02MM | $0.03MM | $0.02MM |
| R&D Expense | $8.87MM | $24.84MM | $29.94MM |
| Income(Loss) | $-12.65MM | $-31.62MM | $-36.14MM |
| Taxes | $0.00MM | $0.01MM | $0.01MM |
| Profit(Loss)* | $-12.65MM | $-31.63MM | $-36.14MM |
| Stockholders Equity | $41.50MM | $90.43MM | $145.82MM |
| Inventory | $0.02MM | $0.00MM | $0.00MM |
| Assets | $44.27MM | $94.64MM | $152.13MM |
| Operating Cash Flow | $-11.46MM | $-29.84MM | $-29.23MM |
| Capital expenditure | $0.39MM | $0.06MM | $0.15MM |
| Investing Cash Flow | $-0.39MM | $-0.06MM | $-110.57MM |
| Financing Cash Flow | $36.96MM | $75.96MM | $83.59MM |
| Earnings Per Share** | $-0.63 | $-1.19 | $-1.18 |
| Ordinary share to ADR | 0.50x | 0.50x | 0.50x |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.